Loading…
Loading…
California State Teachers Retirement System boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 37,390.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 124,019,670 shares of the company's stock after buying an additional 123,688,863 shares during the quarter. California
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
Allen Mooney and Barnes Investment Advisors LLC cut its stake in Elevance Health, Inc. (NYSE: ELV) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,398 shares of the company's stock after selling 3,218 shares during the quarter.
Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and
B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,408 shares of the company's stock, valued at approximately $12,146,000. Other institutional investors have also